On a sunny afternoon on Friday, May 11th, AMAC Delegates Charles Abbey (VA-05) and Rex Jamieson (VA-11) attended a Rose Garden announcement with President Trump as he unveiled his blueprint to lower drug prices and reduce out-of-pocket costs.
Aptly named “American Patients First,” AMAC listened to both President Trump and Health and Human Services (HHS) Secretary Alex Azar as they outlined their plans to share rebates, streamline production of generics, and target the middlemen who artificially inflate drug costs.
“One of my greatest priorities is to reduce the price of prescription drugs,” President Trump said. “In many other countries, these drugs cost far less than what we pay in the United States. That is why I have directed my Administration to make fixing the injustice of high drug prices one of our top priorities. Prices will come down.”
Secretary Azar, a former executive at a large pharmaceutical company, also emphasized the need for a full-scale, comprehensive plan to drive down drug costs—particularly for senior citizens. Highlighting his work with the Administration, Secretary Azar committed HHS to finding innovative solutions to bring down the over-inflated cost of drugs.
For several years, AMAC has been advocating that healthcare, and particularly drugs, are far too expensive. It was an honor to have AMAC representatives attend the Rose Garden announcement, and hear how President Trump is fighting for seniors to make their drugs more affordable.